Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC 1 national cross-sectional study

MLA

Mercader-García P, et al. Should Methyldibromo Glutaronitrile Continue to Be Used in the European Baseline Series? A REIDAC 1 National Cross-Sectional Study. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....59af089d197f85abd2738d33786c5068&authtype=sso&custid=ns315887.

APA

Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Cordoba-Guijarro S, Jimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Ortiz-Frutos FJ, Sanz-Sanchez T, Rodriguez-Serna M, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Zaragoza-Ninet V, Hervella-Garces M, Gatica-Ortega ME, … Borrego L. (2021). Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC 1 national cross-sectional study.

Chicago

Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Cordoba-Guijarro S, Jimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, et al. 2021. “Should Methyldibromo Glutaronitrile Continue to Be Used in the European Baseline Series? A REIDAC 1 National Cross-Sectional Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....59af089d197f85abd2738d33786c5068&authtype=sso&custid=ns315887.